Your fact-checks will appear here
German multinational pharmaceutical, chemical, and agricultural biotechnology company
2025 inaugural fundraising was unprecedented in scale, drawing well over $170 million and by some counts approaching or exceeding $240–245 million — with accounting for roughly $161 million of that to...
Campaign finance records and industry studies show pharmaceutical companies and associated PACs gave hundreds of millions to U.S. politics across multiple decades and cycles — for example, OpenSecrets...
The American Heart Association (AHA) regularly discloses a multi-year roster of corporate donors that includes numerous pharmaceutical, biotech and medical-device firms; its published “pharma funding”...
The American Heart Association (AHA) publishes year-by-year disclosures listing pharmaceutical, biotech and device-company support, and those disclosures show a recurring set of large donors across th...
No reporting in the supplied sources identifies a plaintiff group currently suing Donald Trump in a case described as “cancer‑related”; instead the documents describe (a) private plaintiffs suing Mons...
There is no record in the supplied reporting of Robert F. Kennedy Jr. explicitly "admitting" that President Trump accepted money from pharmaceutical lobbyists; what is documented is that major pharmac...
Available sources in the provided search results do not mention any product named “keryleaf” and do not state whether it is approved or regulated by the U.S. Food and Drug Administration or other heal...
Coverage in the provided sources does not describe a single named “the lawsuit” or a direct back‑and‑forth outcome between two particular parties; instead, reporting shows several separate cases where...